XML 22 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements Of Changes Of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Consolidated Statements Of Changes Of Cash Flows [Abstract]    
Net income $ 4,477 $ 479
Adjustments to reconcile net loss to net cash from operating activities:    
Provision for loan losses 250 278
Depreciation 211 232
Amortization, net 25 189
Deferred income tax (benefit) (3,251)  
Net loss on sales of securitites 12  
Originations of loans held for sale (41,617) (50,140)
Proceeds from sale of loans held for sale 44,830 50,456
Net gains on sales of loans (325) (536)
Earnings on bank owned life insurance (132) (130)
Stock-based compensation expense 134 265
Net change in:    
Accrued interest receivable and other assets 993 (240)
Accrued interest payable and other liabilities (505) 202
Net cash from (used by) operating activities 5,102 1,055
Cash flows from investing activities    
Net decrease in interest-bearing deposits in other financial institutions 494 1,488
Available-for-sale securities:    
Maturities, prepayments and calls 5,509 4,073
Purchases (4,573) (5,019)
Loan originations and payments, net (44,531) (50,998)
Proceeds from the sale of loans 4,099  
Additions to premises and equipment (45) (461)
Net cash used by investing activities (39,047) (50,917)
Cash flows from financing activities    
Net change in deposits 32,128 49,973
Net change in other debt   (6,526)
Proceeds from FHLB advances 2,500 22,500
Repayments on FHLB advances (2,500) (18,000)
Net change in advances by borrowers for taxes and insurance 255 (174)
Cash dividends paid on Series B preferred stock (750) (233)
Net proceeds from issuance of Series B preferred stock   11,369
Net cash from (used by) financing activities 31,633 58,909
Net change in cash and cash equivalents (2,312) 9,047
Beginning cash and cash equivalents 28,207 19,160
Ending cash and cash equivalents 25,895 28,207
Supplemental cash flow information:    
Interest paid 2,612 2,097
Supplemental noncash disclosures:    
Loans transferred from held for sale to portfolio 1,833  
Loans transferred from portfolio to held for sale 1,561  
Dividends payable on Series B preferred stock $ 187 $ 187